January 10, 2017
Via: FortuneFrench cosmetics group L’Oreal (LRLCY) is acquiring three specialized skincare brands – CeraVe, AcneFree and Ambi – from Canada’s Valeant Pharmaceuticals International (VRX) for $1.3 billion in cash to expand into one of the fastest growing areas of the beauty […]
November 8, 2016
Via: FortuneValeant Pharmaceuticals International reported a smaller-than-expected quarterly profit due to faltering sales of its dermatology products and irritable bowel syndrome drug, and the company cut its full-year profit and revenue forecasts. Valeant’s U.S.-listed shares fell more than 10% in premarket […]
August 12, 2016
Via: CNBCShares of Valeant Pharmaceuticals fell nearly 10.4 percent on Thursday after The Wall Street Journal reported the pharmaceutical company is under federal investigation for allegations it defrauded insurers by hiding its ties to Philidor, a mail-order pharmacy unit. The Journal […]
November 24, 2015
Via: Market WatchWilliam Ackman’s Pershing Square Capital Management LP disclosed an increased 9.9% stake in Valeant Pharmaceuticals International Inc. VRX, -3.95% , a move that comes after the hedge-fund manager said he had taken advantage of the beaten-down market for the stock […]
October 30, 2015
Via: itCuratedSource photo The two largest pharmacy-benefit managers in the U.S. said they’re ceasing work with a pharmacy used by Valeant Pharmaceuticals International Inc., dealing another blow to Valeant. VRX, -4.70% CVS Health Corp. CVS, -0.01% said it is terminating pharmacy […]
October 28, 2015
Via: itCuratedImagine this: You own a business. A giant competitor comes and offers to buy it, but allows you to continue running it. Then, after you sign the sale agreement, you start to think this giant wants you to do things […]
May 12, 2023
Copyright © 2023. All rights reserved
